Cancer letters最新文献

筛选
英文 中文
The HDAC2/KAT2A-Lamin A Lactylation Axis Regulates Tumor Progression and Chemoresistance in Bladder Cancer. HDAC2/KAT2A-Lamin A乳酸化轴调控膀胱癌的肿瘤进展和化疗耐药。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-14 DOI: 10.1016/j.canlet.2026.218968
Guanghui Xu, Wei Zhao, Yuqin Li, Shuting Fang, Zhigang Wu, Minghao Zheng, Yongming Deng, Xi Zheng, Hongqian Guo, Wenli Diao, Junlong Zhuang
{"title":"The HDAC2/KAT2A-Lamin A Lactylation Axis Regulates Tumor Progression and Chemoresistance in Bladder Cancer.","authors":"Guanghui Xu, Wei Zhao, Yuqin Li, Shuting Fang, Zhigang Wu, Minghao Zheng, Yongming Deng, Xi Zheng, Hongqian Guo, Wenli Diao, Junlong Zhuang","doi":"10.1016/j.canlet.2026.218968","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218968","url":null,"abstract":"<p><p>Lysine lactylation (Kla) is a post-translational modification implicated in tumor metabolic reprogramming, yet its functional significance in bladder cancer remains largely unexplored. Here, we identify lactylation of Lamin A in bladder cancer and elucidate its regulatory mechanisms in cisplatin resistance. Integrated lactylome and proteome profiling combined with mass spectrometry reveal that Lamin A is lactylated at K233 and K417, which are significantly elevated in bladder cancer tissues. Functional characterization demonstrates that lactylation of Lamin A suppresses tumor proliferation, inhibits migration, induces G1 cell cycle arrest, promotes apoptosis, and thus enhances cisplatin sensitivity, whereas lactylation-deficient mutants abrogate these effects, with K233 and K417 as the critical functional residues. Mechanistically, Lamin A delactylation enhances the binding between MRE11 and ATM, promotes the recruitment of MRE11 to DSB sites and activates the downstream CHK1/CHK2 signaling pathway, thereby promoting DNA repair and conferring cisplatin resistance. We further identify HDAC2 and KAT2A as the delactylase and lactyltransferase of Lamin A, respectively, with HDAC2 driving malignant phenotypes through K233 and K417 delactylation. Pharmacological inhibition of HDAC2 with entinostat effectively suppresses xenograft tumor growth in vivo in a Lamin A lactylation-dependent manner. Collectively, our findings define Lamin A lactylation as a tumor-suppressive modification and uncover the HDAC2/KAT2A-Lamin A axis as a critical factor of cisplatin response, suggesting that targeting this pathway may represent a promising therapeutic strategy for bladder cancer.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218968"},"PeriodicalIF":11.8,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Amplification of ABCB1-harboring extrachromosomal amplicons endows gallbladder cancer with bortezomib resistance. 携带abcb1染色体外扩增子的扩增使胆囊癌具有硼替佐米耐药性。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-13 DOI: 10.1016/j.canlet.2026.218973
Tianen Chen, Yuchao Sun, Yukai Shan, Shijie Li, Win Topatana, Sarun Juengpanich, Ziyi Lu, Tianao Xie, Ruijing Shen, Xueyin Zhou, Mingyu Chen, Xiujun Cai
{"title":"Amplification of ABCB1-harboring extrachromosomal amplicons endows gallbladder cancer with bortezomib resistance.","authors":"Tianen Chen, Yuchao Sun, Yukai Shan, Shijie Li, Win Topatana, Sarun Juengpanich, Ziyi Lu, Tianao Xie, Ruijing Shen, Xueyin Zhou, Mingyu Chen, Xiujun Cai","doi":"10.1016/j.canlet.2026.218973","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218973","url":null,"abstract":"<p><p>Gallbladder cancer (GBC) is an aggressive malignancy with limited treatment options for advanced disease. Bortezomib (BTZ) has shown activity against biliary tract cancers, but acquired resistance severely undermines its clinical benefit. To elucidate the underlying mechanisms and identify strategies to reverse resistance, we established a BTZ-resistant GBC-SD cell line. Resistant cells overexpressed plasma membrane-localized P-glycoprotein (P-gp), exhibited efflux of multiple substrates, and acquired cross-resistance to other proteasome inhibitors, confirming multidrug resistance (MDR). Pharmacological inhibition with tariquidar or genetic ablation of ABCB1 reversed MDR in vitro and suppressed tumor growth in xenograft models. Whole-genome sequencing and bioinformatics revealed ABCB1 amplification within a putative circular amplicon, indicative of extrachromosomal DNA (ecDNA), and identified single-nucleotide polymorphisms associated with resistance. Proximity labeling coupled with mass spectrometry further identified histone H1 and HNRNPU as key regulators of the amplicon. Collectively, our findings demonstrate that ecDNA-mediated ABCB1 amplification drives P-gp overexpression and MDR in GBC, and that this resistance can be effectively reversed by targeting P-gp or the amplicon complex. This work provides a mechanistic foundation for developing therapeutic strategies to overcome ecDNA-driven drug resistance in GBC and other refractory malignancies.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218973"},"PeriodicalIF":11.8,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Restoring Activation-Linked Clusterin Loss Attenuates Tumor-Directed T Cell Dysfunction Associated with Reduced Translation and Proteostatic Stress. 恢复激活相关的簇蛋白缺失可减弱与翻译减少和蛋白酶抑制应激相关的肿瘤定向T细胞功能障碍。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-13 DOI: 10.1016/j.canlet.2026.218948
Constantin Segner, Julia Höbart, Busheng Xue, Elena Sotillo, Yidan Wang, Mansour Poorebrahim, Yue Yuan, Yue Z Huang, Julia Frede, Michael Lizardo, Julia Mergner, Fares Burwag, Miriam Schulz, Andrew Minchinton, Christian Brückner, Alissia Fernandes Madeira, Julia Hauer, Pengcheng He, Crystal Mackall, Jürgen Ruland, Poul H Sorensen, Stefan E G Burdach
{"title":"Restoring Activation-Linked Clusterin Loss Attenuates Tumor-Directed T Cell Dysfunction Associated with Reduced Translation and Proteostatic Stress.","authors":"Constantin Segner, Julia Höbart, Busheng Xue, Elena Sotillo, Yidan Wang, Mansour Poorebrahim, Yue Yuan, Yue Z Huang, Julia Frede, Michael Lizardo, Julia Mergner, Fares Burwag, Miriam Schulz, Andrew Minchinton, Christian Brückner, Alissia Fernandes Madeira, Julia Hauer, Pengcheng He, Crystal Mackall, Jürgen Ruland, Poul H Sorensen, Stefan E G Burdach","doi":"10.1016/j.canlet.2026.218948","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218948","url":null,"abstract":"<p><p>T cell therapies with chimeric antigen receptor (CAR) T cells or T cell receptor (TCR) transgenic (tg) T cells are a promising approach in the treatment of solid malignancies but are limited by T cell exhaustion caused by chronic antigen stimulation. Clusterin (CLU) is a stress-associated molecular chaperone with cytoprotective functions in normal and malignant cells, but its role in therapeutic T cells is unclear. Here, we found that CLU expression is reduced in exhausted tumor-infiltrating lymphocytes and decreases after prolonged stimulation of Ewing sarcoma (EwS)-directed TCR-transgenic T cells and GD2 CAR-T cells. To test whether reconstituting CLU affects T cell fitness, we engineered CHM1/HLA-A*02:01-directed ChoTCR-T cells and GD2 CAR-T cells to overexpress CLU. In ChoTCR-T cells, CLU overexpression reduced exhaustion- and apoptosis-associated features after repetitive tumor stimulation while preserving cytotoxicity. CLU-engineered ChoTCR-T cells showed improved infiltration of EwS spheroids, and moderately improved antitumor activity in a metastatic EwS model. Supportive experiments in a GD2/Nalm6 chronic-stimulation model indicated preserved CAR-T cell function after repetitive antigen exposure. Mechanistically, proteomics together with direct measurements of global translation and stress-response activation support a model in which CLU reduces proteostasis-linked translational stress during chronic stimulation. These findings identify CLU overexpression as a promising strategy to attenuate chronic-stimulation-associated dysfunction in tumor-directed T cells, as shown in two therapeutic T cell models of cancer in the young.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218948"},"PeriodicalIF":11.8,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aromatase inhibitors beyond hormone-dependent cancers: Mechanisms, preclinical evidence, and emerging clinical applications. 芳香酶抑制剂超越激素依赖性癌症:机制,临床前证据和新兴临床应用。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-13 DOI: 10.1016/j.canlet.2026.218971
Angelo Meoli, Ruslana Mollo, Joanna Kopecka, Simona Saponara, Chiara Riganti
{"title":"Aromatase inhibitors beyond hormone-dependent cancers: Mechanisms, preclinical evidence, and emerging clinical applications.","authors":"Angelo Meoli, Ruslana Mollo, Joanna Kopecka, Simona Saponara, Chiara Riganti","doi":"10.1016/j.canlet.2026.218971","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218971","url":null,"abstract":"<p><p>Aromatase inhibitors (AIs) have transformed the treatment of hormone receptor-positive breast cancer by suppressing estrogen biosynthesis. However, aromatase and estrogen signaling have also been implicated in several malignancies traditionally classified as non-hormone-dependent, where their effects on tumor progression, metabolism, and antitumor immunity appear to depend on tumor type, receptor context, and the tumor microenvironment. This emerging evidence has generated increasing interest in repurposing AIs beyond their conventional endocrine indications. In this review, we summarize the molecular mechanisms linking aromatase and estrogen signaling to oncogenic pathways, tumor metabolism, and modulation of the tumor microenvironment in non-hormone-dependent malignancies. We further discuss preclinical studies demonstrating that AIs not only inhibit intratumoral estrogen production but also enhance the efficacy of chemotherapy and immune checkpoint inhibitors by suppressing pro-survival signaling, reducing PD-L1 expression, reshaping lipid metabolism, and restoring antitumor immune responses. Finally, we critically examine the currently available clinical studies, highlighting both the encouraging biological rationale and the limitations of existing early-phase trials. Overall, aromatase can be considered a broad regulator of cancer biology. Addressing three major challenges - accurate patient stratification, precise identification of predictive biomarkers and design of prospective clinical trials -will be essential to realize the translational potential of AIs and determine whether they can enhance current anticancer treatments.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":"664 ","pages":"218971"},"PeriodicalIF":11.8,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TAM-derived CCL7 Drives CRC Progression and Chemoresistance by Reprogramming Lipid Metabolism via the BATF3/USP22/DGAT2 Axis. tam衍生的CCL7通过BATF3/USP22/DGAT2轴重编程脂质代谢驱动CRC进展和化疗耐药。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-12 DOI: 10.1016/j.canlet.2026.218972
Ye Wang, Tengyi Peng, Zhicheng Zhuang, Bin Chen, Huajun Cai, Zhen Pan, Jinfu Zhuang, Xing Liu, Shoufeng Li, Guoxian Guan, Bingjie Guan
{"title":"TAM-derived CCL7 Drives CRC Progression and Chemoresistance by Reprogramming Lipid Metabolism via the BATF3/USP22/DGAT2 Axis.","authors":"Ye Wang, Tengyi Peng, Zhicheng Zhuang, Bin Chen, Huajun Cai, Zhen Pan, Jinfu Zhuang, Xing Liu, Shoufeng Li, Guoxian Guan, Bingjie Guan","doi":"10.1016/j.canlet.2026.218972","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218972","url":null,"abstract":"<p><p>Colorectal cancer (CRC) is a highly heterogeneous malignancy. Although surgery-based multimodal therapy provides durable benefits for a subset of patients with localized disease, a considerable proportion of patients still experience recurrence or progression post-treatment. Delineating the molecular mechanisms underlying CRC progression and chemoresistance is imperative for identifying therapeutic targets and thereby improving treatment outcomes. Using single-cell RNA sequencing (scRNA-seq), we identified C-C motif chemokine ligand 7 (CCL7) as a key mediator of intercellular communication between tumor-associated macrophages (TAMs) and CRC cells within the tumor microenvironment (TME). TAMs express and secrete high levels of CCL7, which reprograms lipid metabolism in CRC cells, induces the accumulation of lipid droplets (LDs), and markedly promotes CRC cell proliferation and chemoresistance. Elevated CCL7 expression is associated with poor prognosis in patients with CRC. Bulk RNA-seq revealed that CCL7 markedly upregulates the expression of the transcription factor BATF3. Integrating CUT&Tag profiling, HOMER de novo/known motif enrichment analysis, FIMO prediction, co-immunoprecipitation (Co-IP), and dual-luciferase reporter assays, we demonstrated that BATF3 interacts with JunD to synergistically activate the USP22 promoter, thereby upregulating USP22 expression. Furthermore, USP22 deubiquitinates and stabilizes DGAT2, thereby promoting LD accumulation and lipid metabolic reprogramming, which accelerates malignant progression and acquired chemoresistance in CRC. By dissecting the intricate crosstalk within the CRC microenvironment, we elucidated the molecular cascade through which the CCL7-dependent BATF3/USP22/DGAT2 axis drives tumor progression and chemoresistance. Targeting this axis may block lipid metabolic reprogramming and thereby curb these malignant phenotypes, highlighting a promising therapeutic strategy for CRC.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218972"},"PeriodicalIF":11.8,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quercetin suppresses radial glial stem-like cell functions through an HSPB1-associated mechanism in glioma. 槲皮素在胶质瘤中通过hspb1相关机制抑制放射状胶质干细胞样细胞功能。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-12 DOI: 10.1016/j.canlet.2026.218964
Bohan Liu, Zheng Wang, Lijie Huang, Ruoxuan Ni, Rui Tao, Dazhao Peng, Chihyi Liao, Yuge Chen, Ruoyu Huang, Chen Wang, Yankun Chen, Zhiyan Sun, Jiashu Chen, Qiuling Li, Yuedong Hu, Shiyu Liu, Siyuan Yang, Yujinglin Zheng, Huimin Hu
{"title":"Quercetin suppresses radial glial stem-like cell functions through an HSPB1-associated mechanism in glioma.","authors":"Bohan Liu, Zheng Wang, Lijie Huang, Ruoxuan Ni, Rui Tao, Dazhao Peng, Chihyi Liao, Yuge Chen, Ruoyu Huang, Chen Wang, Yankun Chen, Zhiyan Sun, Jiashu Chen, Qiuling Li, Yuedong Hu, Shiyu Liu, Siyuan Yang, Yujinglin Zheng, Huimin Hu","doi":"10.1016/j.canlet.2026.218964","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218964","url":null,"abstract":"<p><p>Glioma is a highly malignant tumor characterized by pronounced intratumoral heterogeneity. By integrating multi-omics analyses, we identified radial glial stem-like (RG-like) cells as a putative upstream developmental-like state in inferred glioma differentiation trajectories. Integrated spatial transcriptomic and histopathological analyses further linked the molecular features of RG-like cells to their spatial distribution and associated tissue morphology. A CRISPR-based knockout screen highlighted heat shock protein beta-1 (HSPB1) as a potential molecular target associated with RG-like cell functions. We subsequently investigated quercetin (QUE) and found that it inhibited glioma cell growth and suppressed mitotic somal translocation (MST), a characteristic RG-like cellular behavior. Mechanistic analyses showed that QUE reduced HSPB1 protein expression and was associated with a reduced detectable interaction between HSPB1 and vimentin (VIM). Together, these findings characterize RG-like cells at the molecular and histopathological levels and suggest that QUE may represent a potential pharmacological approach for modulating their associated functions in glioma.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218964"},"PeriodicalIF":11.8,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Spatial Multi-omics Atlas of Intra- and Extrapancreatic Perineural Invasion Reveals Basal-like Neurotropism and Stromal Remodeling in Pancreatic Cancer. 胰腺内和胰腺外神经浸润的空间多组学图谱揭示了胰腺癌的基底样神经嗜性和基质重塑。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-12 DOI: 10.1016/j.canlet.2026.218974
Bingjun Tang, Fansen Ji, Huan Li, Qi Wang, Sijia Li, Pengfei Wang, Zhe Yan, Yuqian Liang, Yan Wen, Zishuo Wang, Jianghui Yang, Ying Xiao, Hao Liu, Cui Ge, Hongfang Yin, Xuedong Wang, Jiahong Dong
{"title":"A Spatial Multi-omics Atlas of Intra- and Extrapancreatic Perineural Invasion Reveals Basal-like Neurotropism and Stromal Remodeling in Pancreatic Cancer.","authors":"Bingjun Tang, Fansen Ji, Huan Li, Qi Wang, Sijia Li, Pengfei Wang, Zhe Yan, Yuqian Liang, Yan Wen, Zishuo Wang, Jianghui Yang, Ying Xiao, Hao Liu, Cui Ge, Hongfang Yin, Xuedong Wang, Jiahong Dong","doi":"10.1016/j.canlet.2026.218974","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218974","url":null,"abstract":"<p><p>Perineural invasion (PNI) is a prominent feature of pancreatic cancer (PDAC) and is closely associated with tumor progression and poor prognosis. However, its spatial cellular architecture and underlying mechanisms remain incompletely understood. Here, we applied high-resolution spatial transcriptomics to construct a comprehensive atlas of the PNI microenvironment across distinct anatomical regions of intra and extra-pancreas. We observed that the Basal-like tumor subtype exhibited a higher propensity for PNI compared with the Classical subtype, a finding further supported by multiplex imaging on whole-mount histopathology. Comparative spatial analysis revealed distinct immune and stromal organization between tumor subtypes, with enrichment of M2-like macrophage potentially promoting epithelial cell migration in the vicinity of Basal-like tumors. In addition, we identified myofibroblast subset may promote Schwann cell activation and PNI-associated nerve injury was further accompanied by a shift toward inflammatory fibroblast polarization and features of CD8<sup>+</sup> T cell exhaustion within the local microenvironment. Finally, spatial profiling indicated functional heterogeneity among tumor-associated Schwann cells, which may contribute to the tumor progression. Collectively, this study provides a spatially resolved view of the cellular and molecular landscape of PNI in PDAC and offers insights into Basal-specific neurotropic behavior and microenvironmental reorganization.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218974"},"PeriodicalIF":11.8,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The RAS Revolution in Gastrointestinal Cancers: Where We Are and Where We Go Next. RAS在胃肠道癌症中的革命:我们所处的位置和下一步的发展方向。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-12 DOI: 10.1016/j.canlet.2026.218963
Marco Cordani, Murray Korc, Min Li
{"title":"The RAS Revolution in Gastrointestinal Cancers: Where We Are and Where We Go Next.","authors":"Marco Cordani, Murray Korc, Min Li","doi":"10.1016/j.canlet.2026.218963","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218963","url":null,"abstract":"","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218963"},"PeriodicalIF":11.8,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting the CCL5-CCR5 axis protects against chemoresistant mesothelioma development through macrophage reprogramming. 靶向CCL5-CCR5轴通过巨噬细胞重编程防止化疗耐药间皮瘤的发展。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-12 DOI: 10.1016/j.canlet.2026.218950
Laura Gerardelli, Eszter Havrics, Alicia Demanche, Raphaël La Rocca, Maxime Lebrun, Benedetta Bottero, Maëlle Bosmans, Marine Bellefroid, Fabienne Perin, Marco Morbidelli, Raphaël Peiffer, Rebekah Crake, Thomas Marichal, Marie-Julie Nokin, Didier Cataldo
{"title":"Targeting the CCL5-CCR5 axis protects against chemoresistant mesothelioma development through macrophage reprogramming.","authors":"Laura Gerardelli, Eszter Havrics, Alicia Demanche, Raphaël La Rocca, Maxime Lebrun, Benedetta Bottero, Maëlle Bosmans, Marine Bellefroid, Fabienne Perin, Marco Morbidelli, Raphaël Peiffer, Rebekah Crake, Thomas Marichal, Marie-Julie Nokin, Didier Cataldo","doi":"10.1016/j.canlet.2026.218950","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218950","url":null,"abstract":"<p><p>Treatment resistance in pleural mesothelioma (PM) is a clinical challenge. Cisplatin-based chemotherapy remains a cornerstone of treatment, but responses are transient as resistant tumor cells drive disease progression. The contribution of the tumor immune microenvironment to chemoresistance is poorly understood so far. Using cisplatin-resistant murine (AB12, PM27) and human (MSTO-211H) PM models combined with transcriptomics, immune profiling and functional assays, we identify a key role for the CCL5-CCR5 axis in shaping an immunosuppressive niche that supports tumor progression. Resistant cells upregulate and secrete high levels of CCL5, leading to enhanced tumor growth in vivo. Immune profiling of tumor microenvironment reveals a marked recruitment of CCR5<sup>+</sup> macrophages displaying an immunosuppressive phenotype characterized by reduced inflammatory activity. Mechanistically, tumor-derived CCL5 promotes macrophage recruitment and polarization toward a pro-tumoral state through CCR5 signaling. Disruption of this axis, either by pharmacological inhibition of CCR5 using maraviroc or by genetic silencing of CCL5, reduces macrophage infiltration and significantly impairs tumor progression. These findings reveal microenvironment-driven mechanism of chemoresistance in PM and identify the CCL5-CCR5 axis as a key vulnerability. Targeting this pathway may therefore represent a promising therapeutic strategy to limit the progression of cisplatin-resistant mesothelioma by disrupting the tumor-supportive immune microenvironment.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218950"},"PeriodicalIF":11.8,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TAT-Cx43266-283 limits recurrence-associated features and improves survival after tumor resection in preclinical glioblastoma models. TAT-Cx43266-283限制了临床前胶质母细胞瘤模型中肿瘤切除术后的复发相关特征并提高了生存率。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-11 DOI: 10.1016/j.canlet.2026.218960
Andrea Álvarez-Vázquez, María Martínez-Fernández, Enrique Jiménez-Madrona, Josephine Volovetz, Susana Fraile-Martín, Sakura E Chan, Raúl González-Sánchez, Kristen E Kay, Sabrina Z Wang, Samuel A Sprowls, Daniel J Silver, Juyeun Lee, Justin D Lathia, Arantxa Tabernero
{"title":"TAT-Cx43<sub>266-283</sub> limits recurrence-associated features and improves survival after tumor resection in preclinical glioblastoma models.","authors":"Andrea Álvarez-Vázquez, María Martínez-Fernández, Enrique Jiménez-Madrona, Josephine Volovetz, Susana Fraile-Martín, Sakura E Chan, Raúl González-Sánchez, Kristen E Kay, Sabrina Z Wang, Samuel A Sprowls, Daniel J Silver, Juyeun Lee, Justin D Lathia, Arantxa Tabernero","doi":"10.1016/j.canlet.2026.218960","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218960","url":null,"abstract":"<p><p>Glioblastoma (GBM) remains an incurable disease with an extremely poor prognosis. Tumor resection represents a first-line treatment when possible, but most patients suffer tumor recurrence, the primary cause of mortality. One of the functions of connexin43 (Cx43), a gap junction-forming subunit that also has a role in channel-independent signaling, is the inhibition of Src, an oncoprotein involved in tumor progression and recurrence. We previously developed a Cx43 mimetic peptide TAT-Cx43<sub>266-283</sub> that recapitulates the inhibition of Src and exerts antitumor effects in patient-derived and mouse in vitro and in vivo models, and here we aimed to explore its effect in GBM recurrence. Analysis of clinical datasets shows a marked increase of Src activity after the standard of care treatments, suggesting that targeting Src activity could prevent GBM recurrence. Importantly, we found that the combination of tumor resection and TAT-Cx43<sub>266-283</sub> extended survival in two syngeneic, immunocompetent GBM resection models, which recapitulated key complementary histological features of GBM. TAT-Cx43<sub>266-283</sub> in combination with tumor resection increased tumor cell apoptosis and decreased important hallmarks of GBM recurrence by targeting the specific dominant features in each model, such as aberrant vascularization or tumor infiltration. These effects occurred alongside the recruitment of tumor-associated macrophages and microglia (TAMs) to tumor border and their shift towards an antitumor phenotype. Our findings suggest the possible involvement of the immune system in the antitumor effects of TAT-Cx43<sub>266-283</sub> and reveal the efficacy and safety of the intracavitary application of TAT-Cx43<sub>266-283</sub> after tumor resection, supporting its potential in a clinical setting.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218960"},"PeriodicalIF":11.8,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149393015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书